Loading...

Loading...

Adjust height of sidebar

KMap

People

Adjust height of sidebar

KMap

Profile

Picture of Kathleen Rodgers

Kathleen Rodgers

Professor, BIO5 Institute | Professor, Clinical Translational Sciences | Associate Director, Translational Neuroscience | Professor, Pharmacology | Member of the Graduate Faculty

Collaboration(52)

Sairam Parthasarathy
Kenneth Knox
Teshia Solomon
Jarrod Mosier
Bonnie LaFleur

Page 1 of 11

Grants(29)

Page 1 of 6

Publications(22)

Recent

Vivaria housing conditions expose sex differences in brain oxidation, microglial activation, and immune system states in aged hAPOE4 mice

2024

neuroscience, aging, immunology, animal behavior, oxidative stress

Blood pressure variability, central autonomic network dysfunction and cerebral small vessel disease in APOE4 carriers

2023

blood pressure, autonomic network, cerebral small vessel disease, apoe4 carriers, central nervous system

Blood-Derived Progenitor Cells Are Depleted in Older Adults with Cognitive Impairment: A Role for Vascular Resilience?

2023

aging, cognitive impairment, progenitor cells, vascular resilience, blood

A tale of two systems: Lessons learned from mid-life aging with implications for Alzheimer’s Prevention and Treatment

2022

aging, alzheimer's, prevention, treatment, lessons

Association between menopausal hormone therapy and risk of neurodegenerative diseases: Implications for precision hormone therapy.

2021

menopausal hormone therapy, neurodegenerative diseases, precision hormone therapy, association, risk

Increased Levels of Circulating Angiogenic Cells and Signaling Proteins in Older Adults with Cerebral Small Vessel Disease.

2021

angiogenic cells, cerebral small vessel disease, aging, g-protein signaling, circulating levels

Hormone Modulating Breast Cancer Therapies and Incidence of Neurodegenerative Outcomes: A Retrospective Patient Cohort Analysis

2020

cancer, neurodegeneration, hormones, therapies, retrospective analysis

Safety, tolerability and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer’s disease: A phase 1 single and multiple ascending dose clinical phase 1b/2a trial

2020

alzheimer's disease, pharmacokinetics, safety, regenerative therapeutic, clinical trial

Targeting the Renin-Angiotensin System to Reduce Systemic Lupus Erythematosus Related Pathologies in MRL-lpr Mice

2020

renin-angiotensin system, systemic lupus erythematosus, mrl-lpr mice, pathologies, targeting therapy

Endothelial progenitor cells are depleted in older adults with cognitive impairment and white matter volume loss: Molecular and cell biology/vascular factors

2020

cell biology, age related cognitive impairment, vascular factors, white matter volume loss, endothelial progenitor cells